February 28, 2022
Preparing to deliver next-generation therapeutics
Mayo Clinic is among the academic medical centers on the cusp of biomanufacturing next-generation cell and gene therapies that offer hope of new cures for rare and complex diseases. Biomanufacturing this new era of biologic medicines is much different than manufacturing pharmaceuticals from complex molecules. It requires highly specialized lab infrastructure, new processes and new […]
Tags: Allan Dietz, biomedical engineering, CAR-T cell therapy, Center for Regenerative Medicine, clinical trials, Michael Gustafson, personalized medicine